Fig. 1From: Effects of Tocilizumab in COVID-19 patients: a cohort studyProgression of laboratory markers within 14 days of tocilizumab (results shown as median and IQR using Prism GraphPad version 8). Troponin: lower limit of detection < 0.012 ng/ml; D-dimer: upper limit of detection > 20 mcg/mlBack to article page